The aim of the journal is to be a respected international publication while serving as the major venue for Canadian Plastic Surgery, Hand Surgery, Microsurgery, and Aesthetic Surgery within Canada. It will consider for publication original reports of clinical and basic research relevant to plastic surgery, as well as editorials, review articles, case reports, and plastic surgery licensing examination sample questions and answers. Manuscripts on health systems, ethics, medical history, and political and financial issues affecting practice, as well as letters to the editor are also welcomed. The journal is pleased to accept manuscripts in both English and French. Manuscripts are received with the understanding that they are submitted solely to the Plastic Surgery, and that none of the material contained in the manuscript has been previously published or is under consideration for publication elsewhere, with the exception of abstracts.
|Edward W. Buchel||University of Manitoba, Winnipeg, Manitoba, Canada|
|Kimberly Dalke||Winnipeg, Manitoba, Canada|
|Jugpal Arneja||Vancouver, Canada|
|Kirsty Boyd||Ottawa, Canada|
|Nicholas Carr||Vancouver, Canada|
|Mahendra Daya||South Africa|
|Stefan Hofer||Toronto, Canada|
|Donald Hudson||South Africa|
|Steven Kasten||Ann Arbor, USA|
|William Kuzon Jr.||Ann Arbor, USA|
|Donald Lalonde, MD||Dalhousie University, Saint John, NB, Canada|
|Sheina Macadam||Vancouver, Canada|
|Raman Mahabir||Phoenix, USA|
|Steven Morris||Halifax, Australia|
|Julian Pribaz||Boston, USA|
|Andrea Pusic||Memorial Sloan-Kettering Cancer Center, USA|
|Michel Saint-Cyr||Rochester, MN, USA|
|Leif Sigurdson||Winnipeg, Canada|
|John Stein||Halifax, Australia|
|Jin Bo Tang||Affiliated Hospital of Nantong University, Nantong, China|
|Achilleas Thoma, MD, MSc, FRCS(C), FACS||McMaster University, Hamilton, Ontario, Canada|
|Fu-Chan Wei, MD, FACS||Chang Gung University, Taipei, Taiwan|
|Jason Wong||United Kingdom|
Manuscript Submission Guidelines: Plastic Surgery
Plastic Surgery (PS) follows the 10th Edition of the AMA Manual of Style and also recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit https://mc.manuscriptcentral.com/psg to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in PS and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Manuscripts submitted to PS are evaluated by the editorial staff. If the manuscript is potentially suitable, it is subjected to peer review by members of a carefully appointed editorial board.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. Note that most published material is protected by copyright, and reprinting such material without permission is prohibited. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
Conflict of Interest Policy: Authors
Authors should state any potential conflicts of interest at the time of submission of the manuscript. Such information will not alter established editorial and review policies but will assist the editorial staff in avoiding any potential conflicts that could give the appearance of a biased review.
Financial support. To comply with the guidance for research funders, PS requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit Funding Acknowledgements on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding or state in your acknowledgments that: “This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.”
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors. The list of authors should include all those who can legitimately claim authorship. This is all those who:
a) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
b) Drafted the article or revised it critically for important intellectual content,
c) Approved the version to be published,
d) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Exclusive License to Publish
To publish a manuscript, we require a signed Exclusive License to Publish agreement from one author (usually the corresponding author) with the understanding that all authors have seen and agreed to the contents of the manuscript. The form will be reviewed and signed online at the time of acceptance. Under the agreement, the author retains copyright to the work and grants an exclusive license to SAGE to publish the article and its contents.
Employees of the federal government are required to indicate this affiliation on the same form. Any financial disclosures or declarations of potential conflicts of interests should be listed on the agreement.
Preparing Your Manuscript
The first page should include:
• the full title of the paper (punctuation is discouraged, but colons are acceptable)
• the names and locations of the institutions where the work was conducted, with the authors' initial in parentheses after the appropriate institution; for example: Tokyo University (SH, TK).
• the address, telephone number, fax number, and e-mail address of the corresponding author.
The abstract should be informative rather than descriptive, and 250 words or less (≤150 words for Brief Communications and Case Reports). The abstract should briefly summarize the rationale and methods for the study, but most of the abstract should be a detailed summary of the findings and their significance.
Identify 4-8 key words and place them after the abstract in alphabetic order. Use terms from the medical subject headings (MeSH) list of the U.S. National Library of Medicine. If suitable MeSH terms are not yet available, current terms may be used.
Tables should be submitted as separate Word or Excel files, not as part of the main document (manuscript text file). Tables must be editable and cannot be embedded images in a Word document. Each table is identified in the order that the tables are cited in the text (Table 1, Table 2, etc.).
Figure numbering: Figures are numbered (Fig. 1, Fig. 2, etc.) in the order cited in the text. Do not use Fig. 1a, 1b, 1c, etc.
Image file format: Images should be TIF files with a minimum of 300 pixels per inch and at 90 or 180 mm wide (i.e., one column width or two column widths).
Any images of persons where persons are recognizable require permission.
References follow AMA 10th style and should be numbered in order of appearance of in-text citations.
Supplemental material is published electronically on the journal website and does not appear in the print version of the journal, but is readily accessed from the journal’s table of contents online by a hyperlink. In general, supplemental materials may include information that is of value but is not critical for readers to understand the main outcomes of the study, and may also include results that enhance or extend the findings, such as video, tables, figures, or appendices. Please keep in mind that supplemental material is not copyedited or typeset by SAGE Publishing. It is uploaded exactly as it is submitted, and authors do not review proofs of supplemental material.
Please label all supplemental files with “Supplemental” somewhere in the file name.
STATEMENT OF HUMAN AND ANIMAL RIGHTS
PS accepts manuscripts that report human and/or animal studies for publication only if it is made clear that investigations were carried out to a high ethical standard. Studies in humans which might be interpreted as experimental (e.g. controlled trials) should conform to the Declaration of Helsinki http://www.wma.net/en/30publications/10policies/b3/index.html and typescripts must include a statement that the research protocol was approved by the appropriate ethical committee. In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by the ICMJE, http://www.icmje.org/publishing_10register.html). If your trial has been registered, please state this on the Title Page. When reporting experiments on animals, indicate on the Title Page which guideline/law on the care and use of laboratory animals was followed.
All papers reporting animal and human studies must include whether written consent was obtained from the local Ethics Committee or Institutional Review Board. Please ensure that you have provided the full name and institution of the review committee and an Ethics Committee reference number.
For studies with human subjects, please include the following sentence: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.
If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.
If any identifying information about patients is included in the article, the following sentence should also be included: Additional informed consent was obtained from all patients for which identifying information is included in this article.
For studies with animals, please include the following sentence: All institutional and national guidelines for the care and use of laboratory animals were followed.
For articles that do not contain studies with human or animal subjects: Authors must include the following sentence, so that readers are aware that there are no ethical issues with human or animal subjects: This article does not contain any studies with human or animal subjects.
STATEMENT OF INFORMED CONSENT
Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details (names, dates of birth, identity numbers and other information) should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.
The following statement should be included: Informed consent: “Informed consent was obtained from all individual participants included in the study.”
If identifying information about participants is available in the article, the following statement should be included: “Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.”